NCT03043963

Brief Summary

The main purpose of this study is to learn about the influence of two different behavioral interventions (lasting 8 weeks) involving sleep for lowering blood pressure, and to study the mechanisms involved. There is research evidence that healthy sleep promotes heart-health and may decrease blood pressure, and that sensitivity to insufficient or disrupted sleep may be influenced by sex. This research will compare two interventions that are each designed to improve sleep health, and will investigate sex differences in response. The project includes 3 in-hospital stays with biological measurements to evaluate the underlying mechanisms associated with the effectiveness of two different blood pressure lowering behavioral interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 6, 2017

Completed
4 days until next milestone

Study Start

First participant enrolled

February 10, 2017

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 21, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2022

Completed
Last Updated

February 21, 2023

Status Verified

February 1, 2023

Enrollment Period

4.6 years

First QC Date

January 30, 2017

Last Update Submit

February 17, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction in 24 hour blood pressure

    24h blood pressure (daily averaged).

    The primary outcome measure will be measured during 3 hospital visit periods of approximately 28 hours each. The primary outcome will be evaluated based on an 8 week behavioral intervention.

Secondary Outcomes (1)

  • Lowering of sleep period blood pressure

    he primary outcome measure will be measured during 3 hospital visit periods ofThe secondary outcome will be evaluated based on an 8 week behavioral intervention.

Study Arms (2)

Sleep Timing

ACTIVE COMPARATOR

Intervention will include basic education concerning sleep hygiene and regularity of sleep timing

Behavioral: Sleep Timing

Sleep Extension

EXPERIMENTAL

Intervention will include basic education concerning sleep hygiene and an extension of the sleep period.

Behavioral: Sleep Extension

Interventions

Sleep ExtensionBEHAVIORAL

Lengthen the duration of sleep time.

Sleep Extension
Sleep TimingBEHAVIORAL

Regularize the timing of the sleep period.

Sleep Timing

Eligibility Criteria

Age25 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pre-hypertension or stage one hypertension (BP ≥120/80 and \<160/100).
  • usual sleep period occurs at night

You may not qualify if:

  • significant active or uncontrolled sleep disorders
  • shiftwork
  • current pregnancy
  • diabetic patients who are insulin dependent (or have HbA1c\>9.0%)
  • current use of hypnotics or clonidine
  • renal/electrolyte disorders and any other condition that the study screening physician considers would significantly impede participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Janet M Mullington, PhD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neurology

Study Record Dates

First Submitted

January 30, 2017

First Posted

February 6, 2017

Study Start

February 10, 2017

Primary Completion

September 21, 2021

Study Completion

September 21, 2022

Last Updated

February 21, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations